---
title: "Cagent Vascular initiates the Serranator POINT FORCE observational registry"
date: "2025-01-29T10:15:44.000Z"
publishedDate: "29 janvier 2025"
summary: "Cagent Vascular has announced the start of the POINT FORCE registry, a postmarket clinical follow-up study of the Serranator percutaneous transluminal angioplasty (PTA) serration balloon catheter. This prospective, multicentre, single-arm study will enrol a minimum of 500 patients at up to 30 centres in the USA."
importance: ""
sourceUrl: "https://vascularnews.com/cagent-vascular-initiates-the-serranator-point-force-observational-registry/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-01-29-cagent-vascular-initiates-the-serranator-point-force-observational-registry"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2021/02/Cagent-Vascular-Serranator-web.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/cagent-vascular-initiates-the-serranator-point-force-observational-registry/"
---

![Cagent Vascular initiates the Serranator POINT FORCE observational registry](https://vascularnews.com/wp-content/uploads/sites/7/2021/02/Cagent-Vascular-Serranator-web.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/cagent-vascular-initiates-the-serranator-point-force-observational-registry/*

## L’essentiel

Cagent Vascular has announced the start of the POINT FORCE registry, a postmarket clinical follow-up study of the Serranator percutaneous transluminal angioplasty (PTA) serration balloon catheter. This prospective, multicentre, single-arm study will enrol a minimum of 500 patients at up to 30 centres in the USA.

## Lien source

https://vascularnews.com/cagent-vascular-initiates-the-serranator-point-force-observational-registry/
